Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)

NCT04315896 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19
Severe Acute Respiratory Syndrome

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo oral tablet

Sponsor

National Institute of Respiratory Diseases, Mexico